[DOI] [PubMed] [Google Scholar] 50.Salmeri N., Vigan P., Cavoretto P., Marci R., Candiani M
The consensus statement does suggest, however, that DPP-4 inhibitors may be appropriate in select populations based on concerns associated with weight gain and hypoglycemia, similar to the AACE and ACE recommendations
However, manufacturer savings programs can bring the cost down significantly: Wegovy starts at $149/month and Zepbound starts at $299/month for the starting dose, though prices increase as your dose goes up
When to Contact Your GP About Taste Changes on Ozempic Whilst metallic taste alone is generally not a cause for immediate medical concern, certain circumstances warrant prompt contact with your GP or diabetes specialist nurse
Compounded versions are not FDA-approved and have not been studied to the same extent